Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.

Cancer immunotherapy means activation of immune system in a patient suffering from cancer. One of the safest and effective treatment options for cancer patients may rely on anti-cancer vaccination. In case you answer yes to any of the following questions, you may consider anti-cancer vaccination as a personalized approach to your cancer:

• Do you suffer from cancer?
• Have you exhausted standard treatment options including chemotherapy, radiotherapy and surgery?
• Have you experienced serious side effects in the course of standard cancer treatment?

Experts from STEM CELL THERAPY 4 ME in collaboration with several European Universities and biotech industry developed unique and patented anti-cancer vaccine  which is derived from patient´s own immune cells that can be easily obtained from peripheral blood. These cells are cultured in vitro to obtain dendritic cells. Dendritic cells are professional cells of the immune system capable of inducing strong anti-cancer responses. In some occasions it is also beneficial to obtain freshly removed tumor tissue from patient undergoing elective surgery. This way the vaccine is directly tailored for each individual patient. In case the autologous tumor tissue is not available, allogeneic tumor cell lines characterized for the presence of universal tumor-associated antigens can be provided instead as a source of tumor antigen.

In general, there are no serious side effects associated with vaccine administration. The patient quality of life may improve dramatically. This type of vaccine can be also produced and administered in earlier stages of cancer to enhance own immune system activation in a fight with tumor cells without significant side effects.

Our clinical specialists have more than 15 years of experience in cancer immunotherapy. It is possible to produce dendritic cell vaccines for clinical application under good manufacturing practice (GMP) rules (Figure 1).

Figure 1: Dendritic cell (DC) vaccine preparation using bacterial ghosts (BGs) – for detailed information, please contact us.